Hirsutism

References

• Friedman CI, Schmidt GE, Kim MH, et al. Serum testosterone concentrations in the evaluation of androgen-producing tumors. Am J Obstet Gynecol 1985: 153(1): 44–9
   PubMed Web of Science ®Google Scholar
• Adashi EY, Rosenwaks Z, Lee PA, et al. Endocrine features of an adrenal-like tumor of the ovary. J Clin Endocrinol Metab 1979: 48(2): 241–5
   PubMed Web of Science ®Google Scholar
• White PC, New MI, Dupont B. Congenital adrenal hyperplasia. N Engl J Med 1987: 316(24): 1519–24
   PubMed Web of Science ®Google Scholar
• Goebelsmann U, Lobo RA. Androgen excess. In: Mishell DR, Davajan V, eds. Infertility, contraception, and reproductive endocrinology. 2d ed. Oradell, NJ: Medical Economics Books, 1986: 303–17
   Google Scholar
• Horton R, Hawks D, Lobo R. 3 Alpha, 17 beta- androstanediol glucuronide in plasma: a marker of androgen anion in idiopathic hirsutism. J Clin Invest 1982: 69(5): 1203–6
   PubMed Web of Science ®Google Scholar
• Serafini P, Ablan F, Lobo RA. 5 Alpha-reductase activity in the genital skin of hirsute women. J Clin Endocrinol Metab 1985: 60(2): 349–55
   PubMed Web of Science ®Google Scholar
• Goldzieher JW, Green JA. The polycystic ovary. I. Clinical and histologic features. J Clin Endocrinol Metab 1962: 22(Mar): 325–38
   PubMedGoogle Scholar
• Maroulis GB. Evaluation of hirsutism and hyperandrogenemia. Fertil Steril 1981: 36(3): 273–305
   PubMed Web of Science ®Google Scholar
• Adashi EY, Rosenwaks Z. Hirsutism and virilization. In: Rosenwaks Z, Benjamin F, Stone ML, eds. Gynecology: principles and practice. New York: Macmillan, 1987: 61146
   Google Scholar
• Glickman SP, Rosenfield RL, Bergenstal RM, et al. Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. J Clin Endocrinol Metab 1982: 55(2): 251–7
   PubMed Web of Science ®Google Scholar
• Pittaway DE. Evaluation and treatment of unresponsive hirsutism. Sex Med Today 1985: 3(Mar): 14–8
   Google Scholar
• Pereira MC, Sobrinho IG, Afonso AM, et al. Is idiopathic hyperprolactinemia a transitional stage toward prolactinoma? Obstet Gynecol 1987: 70(3 Pt 1): 305–8
   PubMed Web of Science ®Google Scholar
• Schwartz U, Moltz L, Brotherton J, et al. The diagnostic value of plasma free testosterone in nontumorous and tumorous hyperandrogenism. Fertil Steril 1983: 40(1): 66–72
   PubMed Web of Science ®Google Scholar
• Luciano AA, Chapter FK, Sherman BM. Hyperprolactinemia in polycystic ovary syndrome. Fertil Steril 1984: 41(5): 719–25
   PubMed Web of Science ®Google Scholar
• Dunn JF, Nisula BC, Rodbard D.Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981: 53(1): 58–68
   PubMed Web of Science ®Google Scholar
• Loric S, Guedhot J, Duron F, et al. Determination of testosterone in serum not bound by sex-hormone-binding globulin: diagnostic value in hirsute women. Clin Chem 1988: 34(9): 1826–9
   PubMed Web of Science ®Google Scholar
• Meldrum DR, Abraham GE. Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors. Obstet Gynecol 1979: 53(1): 36–43
   PubMed Web of Science ®Google Scholar
• Lobo RA Paul WL, Goebelsmann U. Serum levels of DHEAS in gynecologic endocrinopathy and infertility. Obstet Gynecol 1981: 57(5): 607–12
   PubMed Web of Science ®Google Scholar
• Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935: 29(2): 181–91
   Google Scholar
• Cumming DC. Polycystic ovarian disease. Fem Patient 1987: 12(Sep): 19–64
   Google Scholar
• Abraham GE, Maroulis GB, Boyers SP, et al. Dexamethasone suppression test in the management of hyperandrogenized patients. Obstet Gynecol 1981: 57(2): 158–65
   PubMed Web of Science ®Google Scholar
• Azziz R. Determining the cause of hirsutism and anovulation. Contemp Obstet Gynecol 1988: 5(May): 126–39
   Google Scholar
• Cumming DC, Yang JC, Rebar RW, et al. Treatment of hirsutism with spironolactone. JAMA 1982: 247(9): 1295–8
   PubMed Web of Science ®Google Scholar
• Helfer EL, Miller JL, Rose LI. Side-effects of spironolactone therapy in the hirsute woman. J Clin Endocrinol Metab 1988: 66(1): 208–11
   PubMed Web of Science ®Google Scholar
• Milewicz A, Silber D, Kirschner MA. Therapeutic effects of spironolactone in polycystic ovary syndrome. Obstet Gynecol 1983: 61(4): 429–32
   PubMed Web of Science ®Google Scholar
• Lobo RA, Shoupe D, Serafini P, et al. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil Steril 1985: 43(2): 200–5
   PubMed Web of Science ®Google Scholar
• Cullberg G, Hamberger L, Mattsson LA, et al. Effects of a low-dose desogestrel-ethinylesttadiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome. Acta Obstet Gynecol Scand 1985: 64(3): 195–202
   PubMed Web of Science ®Google Scholar
• Wild RA, Umstot ES, Andersen RN, et al. Adrenal function in hirsutism. II. Effect of an oral contraceptive. J Clin Endocrinol Metab 1982: 54(4): 676–81
   PubMed Web of Science ®Google Scholar
• Carr BR, Paiker CR Jr, Madden JD, et al. Plasma levels of adrenocorticotropin and Cortisol in women receiving oial contraceptive steroid treatment. J Clin Endocrinol Metab 1979: 49(3): 346–9
   PubMed Web of Science ®Google Scholar
• Tausk M, de Visser J. Pharmacology of orally active progestational compounds: animal studies. In: Tausk M, ed. International encyclopedia of pharmacology and therapeutics: section 48. Vol 2. Elmsford, NY: Petgamon Press, 1972: 35–216
   Google Scholar
• Garner PR, Poznanski N. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen. J Reprod Med 1984: 29(4): 232–6
   PubMed Web of Science ®Google Scholar
• Amice V, Bercovici JR Nahoul K, et al. Increase in H-Y antigen-positive lymphocytes in hirsute women: effects of cyproterone acetate and estradiol treatment. J Clin Endocrinol Metab 1989: 68(1): 58–62
   PubMed Web of Science ®Google Scholar
• Jones DB, Ibraham I, Edwards CR. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol. Acta Endocrinol (Copenh) 1987: 116(4): 497–501
   Google Scholar
• Schmidt JB, Huber J, Spona J. Parenteral and oral cyproterone acetate treatment in severe hirsutism. Gynecol Obstet Invest 1987: 24(2): 125–30
   PubMed Web of Science ®Google Scholar
• Vigersky RA, Mehlman I, Glass AR, et al. Treatment of hirsute women with cimetidine. N Engl J Med 1980: 303(18): 1042
   PubMed Web of Science ®Google Scholar
• Pittaway DE, Wentz AC. Therapeutic alternatives for the hirsute patient. Drug Ther 1982: 12(4): 97–105
   Google Scholar
• Peereboom-Wynia JD, Stolz E, van Joost T, et al. A comparative study of the effects of electrical epilation of beaid hairs in women with hirsutism by diathermy and by the blend method. Arch Dermatol Res 1985: 278(1): 84–6
   PubMed Web of Science ®Google Scholar
• Adamopoulos DA, Kampyli S, Georgiacodis F, et al. Effects of antiandrogen-estrogen treatment on sexual and endocrine parameters in hirsute women. Arch Sex Behav 1988: 17(5): 421–9
   PubMed Web of Science ®Google Scholar